TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/24 16:04 | 5/9/24 | THRD | Third Harmonic Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holles Natalie C. | CA | DO | CEO | M.d | 85 | 4.20 | 0 | 20 | 2 | 1,219 | D | ||||||||||||||
5/10/24 16:04 | 5/9/24 | THRD | Third Harmonic Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holles Natalie C. | CA | DO | CEO | S.d | -246 | 12.18 | 0 | -20 | -2 | 1,219 | D | ||||||||||||||
4/15/24 16:14 | 4/11/24 | THRD | Third Harmonic Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holles Natalie C. | CA | DO | CEO | M.d | 57 | 4.20 | 0 | 14 | 1 | 1,219 | D | ||||||||||||||
4/15/24 16:14 | 4/11/24 | THRD | Third Harmonic Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holles Natalie C. | CA | DO | CEO | S.d | -165 | 12.19 | 0 | -14 | -1 | 1,219 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |